Jinhai Medical Technology (02225) Announces Participation in the 8th China International Import Expo with Launch of Innovative Navigation-Assisted Spinal Endoscopy Technology

Intelligent Finance APP reported that Jinhai Medical Technology (02225) announced that its indirectly wholly-owned subsidiary, Shanghai Jinhai Medical Technology Co., Ltd. (Jinhai Medical), is actively preparing to participate in the 8th China International Import Expo (CIIE) to be held from November 5 to 10, 2025, in Shanghai, China. During the 8th CIIE, Jinhai Medical will jointly release the latest innovative technology of navigation-guided endoscopic spine surgery developed with Medtronic China Orthopedics and Neurosurgery Business Group (Medtronic China). This technology is expected to be applied in spinal surgeries and is anticipated to open up a new path for the precision and intelligent development of spinal procedures, shorten the learning curve for clinicians in endoscopic spine techniques, and promote more efficient and widespread clinical applications in the future.

Medtronic China is a business unit established by Medtronic, a public limited company incorporated in the Republic of Ireland and listed on the New York Stock Exchange (Stock Code: MDT). Medtronic is a global leader in medical technology, with operations in more than 150 countries and regions worldwide, over 350 office locations, and more than 90,000 employees.

Medtronic's main businesses cover the research, development, manufacturing, distribution, and sales of device-based medical therapies and services in the fields of cardiovascular diseases, neuroscience, medical surgery, and diabetes. Medtronic has production bases in Shanghai, Changzhou, and Chengdu, China. Since the first China International Import Expo (CIIE) in 2018, Medtronic has participated in the CIIE for seven consecutive years, leveraging the expo's strong influence to showcase and accelerate the application of its latest innovative medical technologies and products.